Clinical Trials
2 trialsNCT07625527 2026-06-04
Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
Tianjin Medical University Second Hospital
Phase 2 Not yet recruiting
NCT04200118 2019-12-16
Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
IVI Barcelona
Unknown